Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Lichtwer Pharma

This article was originally published in The Tan Sheet

Executive Summary

Lichtwer Pharma: Ad for the company's Kwai garlic tablets in the February issue of Prevention includes a structure/function claim. The print ad asks: "Concerned about Cholesterol?" and then states that "regular use of Kwai has been shown to reduce the level of cholesterol in the blood. In many individuals, this effect may be observed after 12 weeks of ingestion." The ad includes a disclaimer pointing out that the statement has not been evaluated by FDA. The Dietary Supplement Health & Education Act allows claims about a product's ability to change the structure or function of the body so long as they bear a disclaimer...

Topics

UsernamePublicRestriction

Register

PS083787

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel